Nifty
Sensex
:
:
10583.15
35165.12
6.85 (0.06%)
23.13 (0.07%)

Pharmaceuticals & Drugs

Rating :
33/99

BSE: 532660 | NSE: VIVIMEDLAB

38.10
-1.05 (-2.68%)
15-Nov-2018 | 10:04AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  38.90
  •  38.90
  •  38.00
  •  39.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  149974
  •  57.14
  •  125.30
  •  34.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 322.26
  • 3.92
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,047.22
  • 1.02%
  • 0.36

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 36.58%
  • 4.18%
  • 34.35%
  • FII
  • DII
  • Others
  • 0.46%
  • 0.12%
  • 24.31%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.69
  • -2.57
  • -4.13

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.62
  • 3.09
  • -0.74

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.95
  • 3.26
  • -2.34

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.23
  • 6.74
  • 6.74

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.18
  • 1.05
  • 1.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.90
  • 5.78
  • 5.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
358.54
317.97
12.76%
285.61
436.68
-34.60%
299.58
360.03
-16.79%
282.50
298.37
-5.32%
Expenses
289.74
251.51
15.20%
251.87
259.53
-2.95%
250.68
260.03
-3.60%
219.90
238.06
-7.63%
EBITDA
68.80
66.47
3.51%
33.74
177.15
-80.95%
48.89
100.01
-51.11%
62.60
60.30
3.81%
EBIDTM
19.19%
20.90%
11.82%
40.57%
16.32%
27.78%
22.16%
20.21%
Other Income
5.75
2.66
116.17%
2.87
2.32
23.71%
3.12
3.08
1.30%
0.61
0.92
-33.70%
Interest
19.28
24.23
-20.43%
16.37
18.38
-10.94%
17.18
17.34
-0.92%
21.36
14.94
42.97%
Depreciation
15.87
12.56
26.35%
13.84
12.60
9.84%
13.94
15.47
-9.89%
16.09
14.94
7.70%
PBT
39.40
32.34
21.83%
6.41
148.49
-95.68%
20.89
70.28
-70.28%
25.78
31.34
-17.74%
Tax
10.95
8.44
29.74%
-2.50
41.51
-
-0.03
18.57
-
3.71
4.49
-17.37%
PAT
28.46
23.91
19.03%
8.91
106.98
-91.67%
20.92
51.71
-59.54%
22.07
26.85
-17.80%
PATM
7.94%
7.52%
3.12%
24.50%
6.98%
14.36%
7.81%
9.00%
EPS
3.45
2.92
18.15%
1.30
13.20
-90.15%
2.53
6.38
-60.34%
2.69
3.31
-18.73%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
1,226.23
1,185.66
1,461.91
1,345.63
1,380.10
1,350.83
1,108.80
668.31
416.00
343.49
276.12
Net Sales Growth
-13.22%
-18.90%
8.64%
-2.50%
2.17%
21.83%
65.91%
60.65%
21.11%
24.40%
 
Cost Of Goods Sold
487.07
479.67
536.28
624.05
646.23
656.33
513.27
337.39
236.97
203.49
160.67
Gross Profit
739.16
705.99
925.63
721.58
733.88
694.51
595.52
330.93
179.03
140.00
115.46
GP Margin
60.28%
59.54%
63.32%
53.62%
53.18%
51.41%
53.71%
49.52%
43.04%
40.76%
41.82%
Total Expenditure
1,012.19
970.79
1,057.46
1,122.68
1,158.21
1,166.29
928.00
538.02
329.44
279.13
229.96
Power & Fuel Cost
-
34.73
34.78
38.26
46.70
51.39
44.06
22.33
11.08
8.28
6.62
% Of Sales
-
2.93%
2.38%
2.84%
3.38%
3.80%
3.97%
3.34%
2.66%
2.41%
2.40%
Employee Cost
-
197.78
189.98
176.94
184.43
162.66
50.33
32.19
19.97
22.07
16.77
% Of Sales
-
16.68%
13.00%
13.15%
13.36%
12.04%
4.54%
4.82%
4.80%
6.43%
6.07%
Manufacturing Exp.
-
176.69
175.06
167.31
179.26
182.37
230.50
91.61
32.06
19.82
22.86
% Of Sales
-
14.90%
11.97%
12.43%
12.99%
13.50%
20.79%
13.71%
7.71%
5.77%
8.28%
General & Admin Exp.
-
78.75
93.93
95.26
76.30
86.64
69.34
31.42
15.96
15.29
12.80
% Of Sales
-
6.64%
6.43%
7.08%
5.53%
6.41%
6.25%
4.70%
3.84%
4.45%
4.64%
Selling & Distn. Exp.
-
16.66
15.39
20.86
25.29
26.91
20.50
23.09
11.26
9.32
7.82
% Of Sales
-
1.41%
1.05%
1.55%
1.83%
1.99%
1.85%
3.45%
2.71%
2.71%
2.83%
Miscellaneous Exp.
-
-13.49
12.03
0.00
0.00
0.00
0.00
0.00
2.14
0.86
7.82
% Of Sales
-
-1.14%
0.82%
0%
0%
0%
0%
0%
0.51%
0.25%
0.88%
EBITDA
214.03
214.87
404.45
222.95
221.89
184.54
180.80
130.29
86.56
64.36
46.16
EBITDA Margin
17.45%
18.12%
27.67%
16.57%
16.08%
13.66%
16.31%
19.50%
20.81%
18.74%
16.72%
Other Income
12.35
9.61
8.09
23.63
8.02
35.90
26.33
2.68
1.00
6.84
2.53
Interest
74.19
82.35
67.79
85.26
86.20
67.46
50.44
28.37
22.10
22.82
18.43
Depreciation
59.74
56.42
58.28
61.39
66.18
66.12
58.81
26.79
10.20
8.73
7.15
PBT
92.48
85.71
286.48
99.93
77.54
86.86
97.88
77.82
55.26
39.65
23.11
Tax
12.13
9.62
72.50
16.26
5.49
20.47
14.29
14.68
6.43
8.63
3.76
Tax Rate
13.12%
11.22%
25.31%
16.27%
7.08%
23.57%
14.60%
18.86%
11.64%
21.77%
16.27%
PAT
80.36
77.94
213.97
83.67
72.05
66.39
83.58
63.14
48.83
31.01
19.35
PAT before Minority Interest
82.21
76.09
213.97
83.67
72.05
66.39
83.58
63.14
48.83
31.01
19.35
Minority Interest
1.85
1.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.55%
6.57%
14.64%
6.22%
5.22%
4.91%
7.54%
9.45%
11.74%
9.03%
7.01%
PAT Growth
-61.63%
-63.57%
155.73%
16.13%
8.53%
-20.57%
32.37%
29.31%
57.47%
60.26%
 
Unadjusted EPS
9.97
9.22
26.41
51.64
44.47
40.97
52.04
45.31
48.04
31.12
20.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
1,226.40
734.21
585.15
559.24
560.36
509.14
474.79
196.71
144.86
102.55
Share Capital
341.73
16.20
80.15
80.15
80.15
80.01
144.88
10.16
9.96
9.40
Total Reserves
884.67
718.01
505.00
479.09
477.84
426.77
327.54
177.68
129.94
90.81
Non-Current Liabilities
356.86
503.86
561.11
538.36
532.58
449.68
360.72
148.25
251.48
313.50
Secured Loans
275.90
396.25
206.75
436.44
378.81
255.19
258.03
131.90
234.55
223.77
Unsecured Loans
49.30
57.07
50.52
46.94
40.92
41.73
53.35
0.00
0.74
76.70
Long Term Provisions
7.03
2.19
3.57
3.17
5.16
1.47
1.06
1.69
0.00
0.00
Current Liabilities
790.23
817.39
897.41
800.86
744.42
610.73
463.69
242.44
59.38
31.35
Trade Payables
201.99
178.59
166.74
188.71
190.49
166.28
156.86
44.06
42.35
20.74
Other Current Liabilities
147.64
179.92
285.85
176.38
138.78
116.10
40.79
4.68
0.04
0.01
Short Term Borrowings
385.16
381.47
407.76
389.38
375.43
301.13
232.82
175.08
0.00
0.00
Short Term Provisions
55.43
77.41
37.06
46.39
39.71
27.22
33.21
18.61
17.00
10.61
Total Liabilities
2,385.77
2,055.46
2,043.67
1,898.46
1,837.36
1,569.55
1,299.20
587.40
455.72
447.40
Net Block
1,035.36
878.90
814.17
813.47
807.92
709.04
595.35
264.29
254.72
228.50
Gross Block
1,128.64
915.77
1,663.33
1,599.11
1,526.04
1,329.52
1,167.48
812.71
289.11
254.16
Accumulated Depreciation
93.29
36.87
849.16
785.64
718.12
620.49
572.13
548.42
34.39
25.66
Non Current Assets
1,103.83
961.04
911.03
906.45
846.28
736.20
604.41
266.01
255.86
255.38
Capital Work in Progress
65.27
76.13
94.17
90.28
38.12
26.92
8.37
1.73
1.14
26.88
Non Current Investment
2.70
2.71
2.69
2.70
0.24
0.24
0.70
0.00
0.00
0.00
Long Term Loans & Adv.
0.00
2.81
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.50
0.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,281.94
1,094.42
1,132.60
991.96
970.90
815.08
647.14
314.68
194.06
183.27
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
540.17
483.97
490.80
431.43
426.66
340.26
247.88
84.47
79.35
69.13
Sundry Debtors
275.43
200.14
326.24
329.58
347.83
308.23
221.61
127.56
93.86
70.75
Cash & Bank
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62
16.98
Other Current Assets
367.32
22.53
11.73
19.07
161.84
142.64
141.32
91.55
15.23
26.41
Short Term Loans & Adv.
337.73
332.31
272.88
185.21
139.50
119.82
141.09
89.45
15.20
26.40
Net Current Assets
491.71
277.03
235.19
191.10
226.47
204.35
183.45
72.25
134.67
151.91
Total Assets
2,385.77
2,055.46
2,043.67
1,898.45
1,837.36
1,569.55
1,299.21
587.39
455.73
447.41

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
21.42
57.96
154.12
140.48
-117.65
90.11
45.17
23.89
55.13
-16.82
PBT
85.71
286.48
99.93
77.54
86.86
97.88
77.81
55.26
39.65
23.11
Adjustment
135.90
124.15
101.94
111.32
101.31
80.43
55.16
32.30
30.82
24.98
Changes in Working Capital
-158.14
-315.94
-47.75
-48.38
-305.83
-94.13
-87.81
-63.67
5.89
-47.65
Cash after chg. in Working capital
63.48
94.69
154.12
140.48
-117.65
84.18
45.17
23.89
76.36
0.45
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-42.06
-36.73
0.00
0.00
0.00
5.93
0.00
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-163.53
-68.49
-190.42
-106.71
-291.11
-169.59
-424.15
-72.39
-7.13
-161.07
Net Fixed Assets
38.52
-25.51
-6.97
-49.04
-16.56
-128.68
-148.52
-26.78
7.77
-58.31
Net Investments
-64.27
142.45
0.00
-2.50
-132.00
-8.38
-83.77
0.09
-0.98
0.00
Others
-137.78
-185.43
-183.45
-55.17
-142.55
-32.53
-191.86
-45.70
-13.92
-102.76
Cash from Financing Activity
185.66
35.05
40.59
-41.67
419.37
67.10
404.22
53.98
-59.36
179.33
Net Cash Inflow / Outflow
43.56
24.51
4.29
-7.90
10.62
-12.38
25.24
5.47
-11.35
1.43
Opening Cash & Equivalents
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62
16.98
15.54
Closing Cash & Equivalent
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62
16.98

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
104.60
85.93
64.20
61.00
58.36
52.74
42.03
35.45
26.71
19.24
ROA
3.43%
10.44%
4.25%
3.86%
3.90%
5.83%
6.69%
9.36%
6.87%
5.56%
ROE
9.76%
35.18%
16.50%
14.90%
14.81%
23.34%
26.70%
31.18%
27.74%
23.35%
ROCE
9.04%
21.86%
11.93%
10.91%
11.93%
13.83%
14.29%
17.80%
16.30%
14.14%
Fixed Asset Turnover
1.16
1.13
0.82
0.88
0.95
0.89
0.67
0.76
1.26
1.53
Receivable days
73.20
65.71
88.94
89.58
88.63
87.21
95.35
97.13
87.46
84.05
Inventory Days
157.64
121.69
125.08
113.47
103.61
96.80
90.76
71.87
78.89
76.23
Payable days
70.90
60.76
60.42
57.00
57.11
62.91
65.22
47.96
41.69
34.59
Cash Conversion Cycle
159.93
126.64
153.61
146.05
135.14
121.10
120.89
121.04
124.66
125.69
Total Debt/Equity
0.69
1.45
1.63
1.81
1.66
1.36
1.33
1.70
1.77
3.32
Interest Cover
2.04
5.23
2.17
1.90
2.29
2.94
3.74
3.50
2.74
2.25

News Update:


  • Vivimed Labs’ API manufacturing facility gets EIR from USFDA
    5th Oct 2018, 10:06 AM

    This was a routine inspection by the USFDA

    Read More
  • Vivimed Labs - Quarterly Results
    13th Aug 2018, 17:59 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.